PUMA BIOTECHNOLOGY, INC. (PBYI) › Capital ExpendituresPUMA BIOTECHNOLOGY, INC. (PBYI) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $624.0K2014: $1.10M2015: $1.00M2016: $4.29M2017: $431.0K2018: $439.0K2019: $306.0K2020: $46.0K2021: $02022: $02023: $140.0K2024: $56.0K2025: $71.0K$71.0K2013Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$71.0K+26.8%2024$56.0K-60.0%2023$140.0K—2022$0—2021$0-100.0%2020$46.0K-85.0%2019$306.0K-30.3%2018$439.0K+1.9%2017$431.0K-89.9%2016$4.29M+327.8%2015$1.00M-8.9%2014$1.10M+76.3%2013$624.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share